rxstat › Shortages › Valganciclovir

Valganciclovir shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Valganciclovir products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Feb 28, 2027.
Products affected
2 / 6
In shortage since
Nov 14, 2016
Est. full return
Feb 28, 2027
Reports on file
19
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
AURO-VALGANCICLOVIR
50MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02535483 · since Oct 3, 2025, est. end Feb 28, 2027 · Requirements related to complying with good manufacturing practices.
Active shortage
APO-VALGANCICLOVIR
450MG · TABLET · APOTEX INC
DIN 02393824 · since Nov 14, 2016, no end estimate · Disruption of the manufacture of the drug.
reversed
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825
reversed
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825
reversed
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825
Resolved
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825 · ended Mar 26, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-VALGANCICLOVIR
450MG · TABLET · AURO PHARMA INC
DIN 02435179 · ended Mar 15, 2024 · Demand increase for the drug.
Resolved
VALCYTE
450MG · TABLET · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02245777 · ended Jan 31, 2024 · Delay in shipping of the drug.
Resolved
VALCYTE
450MG · TABLET · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02245777 · ended Nov 2, 2023 · Disruption of the manufacture of the drug.
Resolved
VALCYTE
50MG · POWDER FOR SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02306085 · ended Nov 2, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825 · ended Oct 25, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-VALGANCICLOVIR
450MG · TABLET · TEVA CANADA LIMITED
DIN 02413825 · ended Jun 20, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 19 reports. All reports are on file with Health Canada.

What's happening

Valganciclovir is currently affected by 2 active shortage reports filed with Health Canada by AURO PHARMA INC, APOTEX INC.

The reported causes are: requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Valganciclovir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AB).

Recent changes

Common questions

When will Valganciclovir be back in stock in Canada?

The latest manufacturer estimate is Feb 28, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Valganciclovir in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (direct acting antivirals)

Partial shortageAdefovir Dipivoxil1 of 2 reported products affectedPartial shortageAtazanavir3 of 8 reported products affectedPartial shortageDarunavir2 of 9 reported products affected · est. return Jul 24, 2026Partial shortageEfavirenz1 of 6 reported products affectedPartial shortageEfavirenz Tenofovir Disoproxil Emtricitabine3 of 7 reported products affected · est. return Dec 31, 2026Partial shortageEntecavir2 of 5 reported products affected · est. return Aug 7, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.